J7204 HCPCS Level II code: Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu
J7204 is the HCPCS code for “Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7204Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu
Short description: Inj recombin esperoct per iu
HCPCS · United States
Medicare details
The indicators CMS publishes with J7204 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jul 1, 2020
Where J7204 sits
- 1J codesDrugs administered other than orally
- 2Active code J7204Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7204 mean?
J7204 is the HCPCS code for “Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7204?
CMS lists J7204’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7204
All J codesJ7198Anti-inhibitor, per i.u.J7199Hemophilia clotting factor, not otherwise classifiedJ7200Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iuJ7201Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.J7202Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.J7203Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iuJ7205Injection, factor viii fc fusion protein (recombinant), per iuJ7207Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.J7208Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.J7209Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.J7210Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.J7211Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.